-+ 0.00%
-+ 0.00%
-+ 0.00%

IDEAYA BIOSCIENCES TO ANNOUNCE TOPLINE RESULTS FROM PHASE 2/3 OPTIMUM-02 TRIAL IN METASTATIC UVEAL MELANOMA ON MONDAY, APRIL 13, 2026

Reuters·04/10/2026 20:05:00

Please log in to view news